PTGX·74366E102·US·equity·Healthcare - Biotechnology-13D/G
PTGX (PROTAGONIST THERAPEUTICS INC) is held by 157 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1B), FARALLON CAPITAL MANAGEMENT LLC ($669.2M), UBS Group AG ($545.7M). Net institutional sentiment: Mixed.
See how PTGX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer